The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part II.
IntraMed Scientific Solutions, New York, NY, USA.
Annemarie
A
Armani
Richard C
RC
Becker
D050197:Atherosclerosis / Q000276:immunology* / Q000517:prevention & control; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis / Q000502:physiology*; D002318:Cardiovascular Diseases / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D013927:Thrombosis / Q000276:immunology* / Q000517:prevention & control; D013997:Time Factors
D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002097:C-Reactive Protein